Alembic AAQS

Mitä Alembic tekee? Alembic Ltd. generates revenue primarily through its Pharmaceuticals segment, which focuses on manufacturing and marketing fermentation and chemistry-based Active Pharmaceuticals Ingredients (API). The company produces three key products: Azithromycin, Venlafaxine, and Telmisartan, which are sold to customers in the pharmaceutical industry. These products are manufactured and marketed under the company's own brand, targeting pharmaceutical manufacturers seeking API solutions. The firm's research and development activities in Vadodara support the development of new APIs and enhance its product portfolio. The company operates as a single-segment business, with all operations centered on pharmaceutical manufacturing. Alembic Ltd. does not engage in real estate activities for revenue generation, as the business description specifies that real estate is a separate business line but not a revenue source. The firm's focus remains on API production, with no mention of additional product lines or services beyond the three key products listed. Alembic on yksi Eurpooliin suosituimmista yhtiöistä.